The quest for a male contraceptive that is safe, effective, and entirely reversible has long been described by the medical…
Read More
Discovery of Essential Protein Interaction Complex Unveils New Molecular Mechanisms Governing Sperm Development and Male Infertility
In a groundbreaking study recently published in the Proceedings of the National Academy of Sciences (PNAS), a multi-institutional research team…
Read More
Cornell University Scientists Identify Novel Pathway for Safe and Reversible Nonhormonal Male Contraception
In a breakthrough that could redefine the landscape of reproductive health, researchers at Cornell University have announced a significant advancement…
Read More
Japanese Researchers Identify Key Protein Interaction Regulating Sperm Development and Male Fertility
In a significant advancement for reproductive biology, a multi-institutional research team led by Osaka University has identified a critical protein-to-protein…
Read More
Cornell University Scientists Identify Breakthrough Nonhormonal Path Toward Reversible Long Acting Male Contraception.
In a landmark advancement for reproductive science, researchers at Cornell University have announced a significant breakthrough in the quest for…
Read More
Cornell University Researchers Develop Breakthrough Nonhormonal Male Contraceptive Targeting Cellular Meiosis
In a landmark achievement for reproductive science, researchers at Cornell University have announced a significant advancement in the pursuit of…
Read More
Cornell University Scientists Achieve Breakthrough in Reversible Nonhormonal Male Contraception through Targeted Meiotic Interruption
In a significant advancement for reproductive medicine, researchers at Cornell University have successfully demonstrated a method for a safe, reversible,…
Read More
Cornell University Scientists Identify New Pathway for Reversible Nonhormonal Male Contraceptive Targeting Meiosis
In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant breakthrough in the quest for…
Read More
Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials
Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…
Read More
Molecular Switch Discovery in Sperm Metabolism Paves the Way for Nonhormonal Male Contraceptives and Enhanced Infertility Treatments
Researchers at Michigan State University (MSU) have announced a significant breakthrough in reproductive biology, identifying a specific molecular "switch" that…
Read MoreYOU MAY HAVE MISSED
